R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

a scientist in the lab holds a white mouse model in their gloved hands

Beyond animal testing: How human data trials are reshaping d...

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

R&D

Knowledge Quarter, King's Cross, London, UK

From physics to pharma: How Aqemia is reinventing the future...

The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.

R&D

12 Questions With Trenton M. Johnson

Find out more about Senior Director of CMC Portfolio Management, Thermo Fisher Scientific, Trenton M. Johnson in a new 12 Questions With.

R&D

Leveraging AI agents to eliminate ‘white space’ in clinical ...

Human-AI collaboration has the potential to mitigate gross productivity gaps and establish a new standard of clinical trial efficiency.

R&D

ESMO25: On partnerships between pharma and diagnostic develo...

Jane Li, Senior Director of Pharma CDx and CRO Partnership, Clinical Next Generation Sequencing Business, at Thermo Fisher Scientific discusses CDx.

R&D

Biotech’s biggest challenge isn’t scientific, but political ...

We speak to James Roosevelt Jr, a longtime healthcare leader, former associate commissioner of social security for retirement policy & grandson of FDR